|
|
Product List Page 1682
|
|
Product ID |
Product Name |
CAS# |
Purity |
Y3129016 |
Butane, 4-bromo-1,1-dichloro- |
144873-00-7 |
95% |
D760186 |
Benzenemethanamine, 4-chloro-a-ethyl-, hydrochloride (1:1), (aR)- |
1448902-18-8 |
95+% |
Y1253843 |
Benzo[b]thiophene-2-carboxylic acid, 3-amino-4-fluoro-, methyl ester |
144899-95-6 |
90%(GC) |
D745912 |
1H-Indole-3-ethanamine, 7-methyl- |
14490-05-2 |
95% |
Y1041315 |
Androst-5-ene-7,17-dione, 3-(acetyloxy)-, (3ß)- |
1449-61-2 |
95%+ |
D768313 |
Stannane, tetracyclohexyl- |
1449-55-4 |
95% |
Y3129029 |
Benzaldehyde, 4-(2-methyl-1,3-dioxolan-2-yl)- |
14490-45-0 |
95% |
Y1054754 |
Benzeneacetic acid, 4-chloro-a-[[(1-methylethyl)amino]methyl]-, hydrochloride (1:1), (aS)- |
1449131-17-2 |
95% |
Y3296974 |
1-Piperidinecarboxylic acid, 4-[4-bromo-5-(difluoromethyl)-1H-pyrazol-1-yl]-, 1,1-dimethylethyl ester |
1449117-77-4 |
95% |
Y3310663 |
5,8,11,14,17-Pentaoxa-2-azanonadecanedioic acid, 1-(phenylmethyl) ester |
1449390-66-2 |
98% |
Y1258205 |
4,7,10,13,16,19-Hexaoxaeicosanoic acid, 2,5-dioxo-1-pyrrolidinyl ester |
1449390-12-8 |
97% |
D768314 |
1,2-Pyrrolidinedicarboxylic acid, 3-cyclohexyl-, 1-(1,1-dimethylethyl) ester, (2R,3R)-rel- |
1449586-26-8 |
95% |
Y3314145 |
8H-1,2,4-Triazolo[3,4-c][1,4]oxazinium, 5,6-dihydro-5-(1-methylpropyl)-2-(2,3,4,5,6-pentafluorophenyl)-, (5S)-, tetrafluoroborate(1-) (1:1) |
1449522-21-7 |
98% |
D768315 |
1,2,3,4-Cyclobutanetetracarboxylic acid, 1,2,3,4-tetramethyl ester |
14495-41-1 |
98.0% |
Y3112522 |
Benzenemethanamine, N,N-bis[(trimethylsilyl)methyl]- |
144964-17-0 |
95% |
Y1253900 |
2-Furancarboxaldehyde, 5-propyl- |
14497-27-9 |
95% |
D752894 |
9,10-Anthracenedione, 1,5-diamino-4,8-dihydroxy- |
145-49-3 |
97% |
Y1054757 |
Cholan-24-oic acid, 3,7,12-trioxo-, sodium salt, (5ß)- |
145-41-5 |
98.0% |
Y3104258 |
Pregn-4-en-3-one, 20-hydroxy-, (20R)- |
145-15-3 |
98.0% |
Y1332845 |
Pregn-4-en-3-one, 20-hydroxy-, (20S)- |
145-14-2 |
95% |
Y3129019 |
Benzenemethanamine, 2,4-dichloro-N-(phenylmethyl)- |
14501-87-2 |
95% |
Y3129021 |
2-Thiazolamine, 4-(2-fluorophenyl)- |
145029-82-9 |
95% |
D952129 |
5-Thiazolemethanol, 2-chloro- |
145015-15-2 |
97% |
Y1290591 |
Benzenemethanol, 3-chloro-4-methoxy- |
14503-45-8 |
98% |
D952131 |
L-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 5-methyl ester |
145038-50-2 |
97% |
Y3129203 |
Benzoic acid, 2-(acetyloxy)-5-methyl- |
14504-08-6 |
95% |
Y3129390 |
Methanone, phenyl-2H-tetrazol-5-yl- |
14506-41-3 |
95% |
D768318 |
Benzenemethanol, 4-chloro-a-2-propen-1-yl- |
14506-33-3 |
97% |
D745783 |
2-Thiophenecarboxylic acid, 5-chloro-, 4-nitrophenyl ester |
1450877-56-1 |
97% |
D758547 |
1H-1,2,4-Triazole-1-propanoic acid, a-hydroxy- |
1450828-63-3 |
95% |
D758387 |
Lanthanum hydroxide (La(OH)3) |
14507-19-8 |
99.9% |
D484510 |
3-Pyrrolidinecarbonitrile, 3-amino-1-(phenylmethyl)- |
145090-28-4 |
95% |
Y1249891 |
Carbamic acid, N-[[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]-, ethyl ester |
14511-59-2 |
97% |
D762923 |
3-Thiophenecarboxylic acid, 2,5-dichloro-, methyl ester |
145129-54-0 |
98% |
Y1254214 |
1,3,2-Dioxaborolane, 2-(2,6-difluoro-3-nitrophenyl)-4,4,5,5-tetramethyl- |
1451391-10-8 |
95% |
D952137 |
D-Phenylalanine, 3-methoxy- |
145306-65-6 |
97% |
Y3292453 |
Benzoic acid, 4,4'-[1,5-pentanediylbis(oxy)]bis[5-methoxy-2-nitro- |
145325-48-0 |
97% |
D490977 |
Thieno[2,3-c]pyridine-2-carboxylic acid, 4-bromo-, methyl ester |
145325-40-2 |
97% |
D746191 |
Benzoic acid, 2-chloro-4-iodo- |
145343-76-6 |
98.0% |
Y3264173 |
[1,2,3]Triazolo[1,5-a]pyridine-3-carboxamide |
145335-92-8 |
95% |
Y1337613 |
Boronic acid,(6-butoxy-2-naphthalenyl)- (9CI) |
145369-28-4 |
98% |
Y1254289 |
2-Anthracenesulfonic acid, 1-amino-4-[[3-(ethenylsulfonyl)phenyl]amino]-9,10-dihydro-9,10-dioxo-, sodium salt (1:1) |
14541-90-3 |
>70%(HPLC) |
D965003 |
1-NONADECANOL |
1454-84-8 |
98.0% |
D952139 |
9H-Carbazole, 9-methyl- |
1484-12-4 |
98% |
D758872 |
9H-Carbazole, 9-propyl- |
1484-10-2 |
95+% |
Y1258506 |
9H-Carbazole, 9-(1-methylethyl)- |
1484-09-9 |
97% |
Y1041334 |
Ethanone, 1-(9-ethyl-9H-carbazol-3-yl)- |
1484-04-4 |
98% |
Y1254296 |
Piperidine, 2-ethyl- |
1484-80-6 |
98% |
D763008 |
2H-1-Benzopyran-2-one, 6-ethyl-7-hydroxy-4-methyl- |
1484-73-7 |
95% |
Y3287155 |
Phosphine, bis(bicyclo[2.2.1]hept-2-yl)- |
148432-44-4 |
98%(mixture of endo and exo isomers)(10 wt% in hexanes) |
Y1041337 |
Benzenemethanol, 4-amino-3-methoxy- |
148459-54-5 |
96% |
Y1258602 |
thioperamide maleate salt |
148440-81-7 |
95% |
Y1290170 |
Benzoic acid, 4-cyclopropyl-, methyl ester |
148438-03-3 |
98% |
Y1041338 |
Benzoic acid, 3-(trifluoromethoxy)-, methyl ester |
148438-00-0 |
98% |
Y1041339 |
1H-Indole-5-carboxylic acid, 2,3-dimethyl- |
14844-73-6 |
95+% |
Y3314638 |
ADRENOMEDULLIN (HUMAN) |
148498-78-6 |
95% |
D745705 |
2,1-Benzisoxazole, 5,6-dimethoxy- |
148495-00-5 |
95% |
D768324 |
2-Pyridinecarboxamide, N-methoxy-N-methyl- |
148493-07-6 |
95% |
D745784 |
3-Quinolinecarboxylic acid, 2-cyclopropyl-4-(4-fluorophenyl)-, ethyl ester |
148516-11-4 |
97% |
D962947 |
L-Valine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]oxy]-4-methoxyphenyl]methyl]- |
148515-86-0 |
98% |
D964162 |
L-Alanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]oxy]-4-methoxyphenyl]methyl]- |
148515-85-9 |
98% |
Y3316700 |
Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]oxy]-4-methoxyphenyl]methyl]- |
148515-84-8 |
95% |
Y3104484 |
Butanedioic acid, hydroxy-, compd. with piperazine (1:1) (9CI) |
14852-14-3 |
98.0%(T) |
Y3129125 |
2H-Pyran-4-carboxylic acid, 4-(aminomethyl)tetrahydro-, hydrochloride (1:1) |
1485427-12-0 |
90% |
D952141 |
Boronic acid, B-[3-[(dimethylamino)methyl]phenyl]-, hydrochloride (1:1) |
1485417-01-3 |
97% |
Y1258632 |
5-Thiazolecarboxylic acid, 2,3-dihydro-2-thioxo-, ethyl ester |
1485286-94-9 |
95% |
Y1258603 |
1,3,2-Dioxaborolane, 2-(5-bromopentyl)-4,4,5,5-tetramethyl- |
148562-16-7 |
95% |
Y1333638 |
Boronic acid, B-(6-bromohexyl)- |
148562-12-3 |
95% |
Y3104446 |
2-Piperidinecarboxylic acid, 1-[oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]acetyl]-, monosodium salt, [2R-[2a,2(S*),3a,6ß[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- (9CI) |
148554-65-8 |
98% |
Y1347425 |
(R)-3-(Aminomethyl)-5-methylhexanoic acid |
148553-51-9 |
95% |
Y1258679 |
Benzenaminium, 4-[[4-(dimethylamino)phenyl][4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-N,N-dimethyl-, bromide chloride (1:1:1) |
14855-76-6 |
90% |
Y3129218 |
ß-D-Glucopyranoside, dodecyl 4-O-a-D-glucopyranosyl-1-thio- |
148565-58-6 |
95% |
Y3309924 |
ß-D-Glucopyranoside, nonyl 4-O-a-D-glucopyranosyl-1-thio- |
148565-55-3 |
95% |
Y1258680 |
Carbonic acid, bis(2-ethylhexyl) ester |
14858-73-2 |
95%+ |
Y1041343 |
Benzoic acid, 4-(phenylmethoxy)- |
1486-51-7 |
98% |
D745785 |
Benzoic acid, 3,4,5-tris(phenylmethoxy)- |
1486-48-2 |
95% |
Y1041344 |
Phosphine, methyldiphenyl- |
1486-28-8 |
98% |
Y3111649 |
4H-1-Benzopyran-4-one, 7-hydroxy-2-(4-hydroxyphenyl)-3,5-dimethoxy- |
1486-65-3 |
95% |
D952143 |
Benzoic acid, 3-methoxy-4-(phenylmethoxy)- |
1486-53-9 |
98% |
Y3129271 |
2H-1,4-Thiazin-2-one, 5,6-dihydro-3-(methylamino)-, oxime |
148639-72-9 |
95% |
Y1262895 |
1,2-Propanediol, 3,3,3-trifluoro-, (2R)- |
148683-13-0 |
95% |
Y1258691 |
Ethanone, 2-ethoxy-1-phenyl- |
14869-39-7 |
98% |
Y3129277 |
2-Propanone, 1-ethoxy- |
14869-34-2 |
95% |
D745928 |
Propanedinitrile, 2,2'-(2,5-dimethyl-2,5-cyclohexadiene-1,4-diylidene)bis- |
1487-82-7 |
98.0% |
D755624 |
Benzoic acid, 4-[(aminoiminomethyl)amino]-, methanesulfonate (1:1) |
148720-07-4 |
98.0% |
Y3113126 |
4H-Thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, 7,7-dioxide, (6S)- |
148719-91-9 |
95% |
Y3293679 |
ß-D-Glucopyranoside, 4-nitrophenyl O-ß-D-galactopyranosyl-(13)-O-2-(acetylamino)-2-deoxy-ß-D-glucopyranosyl-(13)-O-ß-D-galactopyranosyl-(14)- |
148705-09-3 |
97.0%(HPLC) |
D768328 |
Platinum, bis(benzonitrile)dichloro- |
14873-63-3 |
41.0% |
D768329 |
2-Naphthalenemethanamine, 5,6,7,8-tetrahydro-5,5,8,8-tetramethyl- |
148749-58-0 |
95% |
Y3129221 |
2-Pyrrolidinone, 3-bromo-1-cyclopropyl- |
148776-25-4 |
95% |
Y1258301 |
1H-Imidazol-1-yloxy,2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide, potassium salt(1:1) |
148819-94-7 |
98% |
Y1266937 |
Quinoxaline, 2-(trifluoromethyl)- |
148853-42-3 |
98% |
Y1253867 |
2H-2-Benzazepine-2-acetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-1,3,4,5-tetrahydro-3-oxo-, (4S)- |
148842-86-8 |
99% (HPLC) |
Y1041348 |
Boronic acid, B-(5-chloro-2-methylphenyl)- |
148839-33-2 |
98%+ |
Y1339816 |
Oxazole, 2-(2-bromophenyl)-4,5-dihydro-4-(1-methylethyl)-, (4S)- |
148836-24-2 |
98% |
Y3110672 |
5'-Guanylic acid, monoanhydride with imidodiphosphoric acid, trisodium salt (9CI) |
148892-91-5 |
85% (HPLC) |
Y1341262 |
5H-Pyrrolo[3,4-b]pyrazin-5-one, 6-(5-chloro-2-pyridinyl)-6,7-dihydro- |
148891-53-6 |
95% |
Y1262511 |
[1,2,4]Triazolo[1,5-a][1,3,5]triazin-7-amine |
1489-04-9 |
95% |
Y1258302 |
Benzonitrile, 2-fluoro-6-(1H-pyrrol-1-yl)- |
148901-51-3 |
95% |
D768331 |
4-Morpholineethanimidamide |
14890-25-6 |
95% |
|
|
|
|
|
|